Its localization is both cytoplasmic and nuclear in SiHa (cervical cancer cell line) (Iden et al., 2016) while in 85% of SK-BR-3 breast cancer cells, a nuclear co-localization of MYC and PVT1 was observed (Tseng et al., 2014). This evidence concerns the gene PVT1 and breast carcinoma.